William John Scheessele, Chief Commercial Officer at Humacyte, Inc. (HUMA), bought 5,000 shares at $3.09 ($15K) on 2022-12-13, disclosed to the SEC on 2022-12-15.
Open-market purchase of $15k HUMA by Chief Commercial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |